“…In particular, Aquablation (AquaBeam â ; Procept BioRobotics, Redwood Shores, CA, USA) is a novel technique that does not have a specific MBS billing code, and therefore is not yet able to be captured by these data. As forecasted by previous authors, an increasing prevalence of BPH surgery is expected to contribute to greater incidence of urethral stricture disease; however, the present dataset does not allow us to asses this relationship [43,44]. Furthermore, the use of medical agents not subsidised by the PBS (purchased via 'private' prescription), such as prazosin, tamsulosin, silodosin and herbal supplements, was unable to be quantified.…”